Haloperidol as an antiemetic following abdominal hysterectomy - a comparison with Zofran®

ISRCTN ISRCTN21871435
DOI https://doi.org/10.1186/ISRCTN21871435
Secondary identifying numbers N0558111116
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
17/09/2012
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Andrew White
Scientific

Milton Keynes General NHS Trust
Standing Way
Eaglestone
Milton Keynes
MK6 5LD
United Kingdom

Phone +44 (0)1908 660033
Email andrew.white@mkgeneral.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesFollowing withdrawal of Droperidol can Haloperidol, which has been used in palliative care, give good antiemetic effect following acute surgery?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPost operative antiemetics
InterventionProspective randomised trial.

17/09/2012: Please note that this trial was stopped as the trial objectives were no longer viable
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Haloperidol, ondansetron (Zofran®)
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/10/2001
Completion date30/09/2003
Reason abandoned (if study stopped)Objectives no longer viable

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participantsNot provided at time of registration
Key inclusion criteriaAll American Society of Anesthesiologists (ASA) I - III females undergoing abdominal hysterectomy who give their consent.
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/10/2001
Date of final enrolment30/09/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Milton Keynes General NHS Trust
Milton Keynes
MK6 5LD
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Hospital/treatment centre

Milton Keynes General NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan